Sort
130,381 grants matching “hiv”
GH13-1310, TECHNICAL ASSISTANCE FOR THE TRANSITION OF COMPREHENSIVE HIV
$1,000,000Ruby N Fayorsey · Columbia University · U2G · FY2013 · GH
Improved Diagnosis of Kaposi's Sarcoma-Associated Herpesvirus Infection
$1,000,000Fred Volinsky · Epiphany Biosciences, Inc. · R44 · FY2017 · AI
HIV PREVENTION TRIAL UNIT
$1,000,000University Of Pennsylvania · U01 · FY2000 · AI
Plant-derived HIV neutralizing mAbs for passive immunotherapy in newborn macaques
$1,000,000Yvonne J Rosenberg · Plantvax, Inc. · R44 · FY2016 · AI
Rapid Test for Recent HIV Infection
$1,000,000Patricia E Garrett · Immunetics, Inc. · R44 · FY2015 · AI
PREVENTION OF HIV TRANSMISSION THROUGH STRENGTHENING BLOOD SAFETY IN THE REPUBLIC
$1,000,000David Mvere · National Blood Service Zimbabwe · U2G · FY2011 · PS
A Rapid Point-of-care Diagnostic for C. trachomatis STDs
$1,000,000Richard F Selden · Network Biosystems, Inc. · R44 · FY2013 · AI
Early and accurate diagnosis of pulmonary and extrapulmonary tuberculosis in all patient groups using a circulating pathogen-derived antigen
$1,000,000Thomas W Tombler · Nanopin Technologies, Inc. · R44 · FY2021 · AI
Therapeutic D-peptide Inhibitor of HIV Entry
$1,000,000Alan L Mueller · Navigen, Inc. · R44 · FY2015 · AI
Advanced PML antiviral
$1,000,000Milton H. Werner · Inhibikase Therapeutics · R44 · FY2018 · AI
22nd International AIDS Conference (AIDS 2018), Amsterdam, the Netherlands, 23-27 July 2018
$1,000,000Chris Beyrer · Ias · R13 · FY2018 · AI
Therapeutic D-peptide Inhibitor of HIV Entry
$1,000,000Alan L Mueller · Navigen, Inc. · SB1 · FY2017 · AI
Safety and Efficacy Evaluations of Topical Microbicide/Biomedical Prevention Products in the Repeat Low-Dose Macaque SlV /SHIV Infection Model
$1,000,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2016 · AI
A single antiviral to treat multiple opportunistic infections
$1,000,000Stacy Remiszewski · Evrys Bio, Llc · R44 · FY2021 · AI
THE NATIONAL SURVEY OF FAMILY GROWTH
$1,000,000Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Y01 · FY2019 · HD
Extended follow-up of randomized participants in the INSIGHT START trial
$1,000,000Birgit Grund · University Of Minnesota · U01 · FY2024 · AI
Anti-HIV Therapeutics that Target HIV nuclear Import
$1,000,000International Therapeutics, Inc. · R44 · FY2002 · AI
Improving availability of ImmunoPET via automation of radio-synthesis and quality control of antibody-based HIV imaging PET tracers on a single platform.
$1,000,000Arkadij Elizarov · Trace-Ability, Inc. · R44 · FY2024 · AI
Development and Commercialization of an Innovative Rapid HIV-1 Incidence Assay
$1,000,000Ronald William Mink · Sedia Biosciences Corporation · R44 · FY2016 · AI
Collaborative African Genomics Network (CAFGEN)
$1,000,000Gabriel Anabwani · Botswana Baylor Child/Clincal Ctr/Excell · U54 · FY2016 · AI
BLDG HLTH DEPT CPCTY FOR HIGH IMPCT HIV PREV THRU TECH COOP
$1,000,000Matthew R Golden · University Of Washington · U65 · FY2014 · PS
Genomic and environmental risk factors for cardiometabolic disease in Africans
$1,000,000Michele Michele Ramsay · Wits Health Consortium (Pty), Ltd · U54 · FY2015 · HG
Transgenic Production of CD4-IgG2 for HIV Therapy
$1,000,000Progenics Pharmaceuticals, Inc. · R44 · FY2003 · AI
Therapy and Prophylaxis for Genital Tract Infection
$1,000,000Dominick Auci · Therapyx, Inc. · SB1 · FY2024 · AI
Programatic-Strengthening Medical Education for Improved Health Outcomes in Kenya
$1,000,000James Njogu Kiarie · University Of Nairobi · R24 · FY2010 · TW